Alberta has temporarily suspended a province-wide trial investigating the effectiveness of hydroxychloroquine as a potential treatment for COVID-19.
A spokesperson with Alberta Health confirmed Tuesday that the “clinical trial has been temporarily suspended by the research team so they can review the literature and results from other studies, as is the case with some other clinical trials around HCQ.” The temporary suspension comes as the World Health Organization announced Monday it was temporarily dropping hydroxychloroquine from its global study into experimental COVID-19 treatments, saying that its experts need to review all available evidence to date. [ Sign up for our Health IQ newsletter for the latest coronavirus updates ] WHO